Data stacking up for Roche haemophilia A drug
But analysts concerned over safety.
X
Data stacking up for Roche haemophilia A drug
https://pharmaphorum.com/news/data-stacks-roche-haemophilia-drug/
Novo Nordisk
Novo’s Saxenda label to include cardio data
Label will reflect heart benefit seen in LEADER trial.
Biotech vTv believes small molecule GLP-1 pill can take on big players
Pill could be effective in diabetes, with fewer GI effects.
ADA preview: cardio data in diabetes, drug costs and healthcare reform
Invokana data could suggest cardio benefit for SGLT2 class.
Novo hopes hypoglycaemia data will boost Tresiba
Lower severe hypo risk compared with Lantus – but no cardiac benefit.
AZ’s Bydureon disappoints in diabetes outcomes trial
Results give advantage to Boehringer/Lilly’s Jardiance.